和元生物
(688238)
| 流通市值：44.37亿 | | | 总市值：44.91亿 |
| 流通股本：6.41亿 | | | 总股本：6.49亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 238,694,510.77 | 287,005,381.69 | 360,037,212.35 | 439,444,851.83 |
| 交易性金融资产 | 50,002,454.99 | - | 20,084,032.41 | 30,259,112.69 |
| 应收票据及应收账款 | 82,023,646.74 | 84,587,907.92 | 85,004,384.18 | 78,038,792.58 |
| 其中：应收票据 | 1,453,500 | 1,453,500 | 1,164,000 | - |
| 应收账款 | 80,570,146.74 | 83,134,407.92 | 83,840,384.18 | 78,038,792.58 |
| 应收款项融资 | - | 1,164,000 | - | - |
| 预付款项 | 8,923,964.84 | 7,091,200.53 | 6,858,981.61 | 7,667,962.11 |
| 其他应收款合计 | 2,426,851.43 | 697,727.6 | 642,930.15 | 409,744.19 |
| 存货 | 78,766,913.8 | 77,515,566.23 | 73,006,042.05 | 73,753,219.25 |
| 合同资产 | 23,685,961.98 | 24,500,087.64 | 21,460,087.74 | 21,110,474.52 |
| 其他流动资产 | 52,327,773.1 | 46,673,382.42 | 44,502,616.67 | 39,742,359.58 |
| 流动资产合计 | 536,852,077.65 | 529,235,254.03 | 611,596,287.16 | 690,426,516.75 |
| 非流动资产: | | | | |
| 长期股权投资 | 62,567,560.19 | 62,827,788.45 | 66,609,731.2 | 66,340,995.43 |
| 其他权益工具投资 | 64,669,912.19 | 75,648,571.28 | 49,391,160 | 48,499,140.56 |
| 固定资产 | 1,301,109,834.84 | 1,313,090,241.08 | 1,298,357,300.14 | 1,317,694,551.8 |
| 在建工程 | 49,536,746.71 | 52,100,067.03 | 79,075,165.05 | 71,190,701.86 |
| 使用权资产 | 14,282,358.43 | 823,729.05 | 884,001.9 | 944,274.75 |
| 无形资产 | 53,787,342.47 | 54,095,816.63 | 54,484,912.22 | 54,985,874.12 |
| 长期待摊费用 | 2,872,108.98 | 3,552,242.37 | 4,232,375.76 | 4,912,509.15 |
| 递延所得税资产 | 31,293,770.11 | 28,079,134.75 | 29,719,785.77 | 29,746,176.6 |
| 非流动资产合计 | 1,580,119,633.92 | 1,590,217,590.64 | 1,582,754,432.04 | 1,594,314,224.27 |
| 资产总计 | 2,116,971,711.57 | 2,119,452,844.67 | 2,194,350,719.2 | 2,284,740,741.02 |
| 流动负债: | | | | |
| 短期借款 | 244,653,985.94 | 204,713,214.99 | 180,747,694.41 | 70,051,333.34 |
| 应付票据及应付账款 | 106,264,585.82 | 109,210,149.68 | 117,117,349.82 | 182,816,057.52 |
| 其中：应付票据 | - | - | 486,000 | 486,000 |
| 应付账款 | 106,264,585.82 | 109,210,149.68 | 116,631,349.82 | 182,330,057.52 |
| 合同负债 | 34,077,482.97 | 26,220,686.81 | 25,416,589.53 | 30,091,175.18 |
| 应付职工薪酬 | 12,419,210.53 | 10,970,416.83 | 12,859,089.52 | 16,567,958.07 |
| 应交税费 | 2,917,039.05 | 2,505,985.07 | 2,279,148.03 | 3,163,983 |
| 其他应付款合计 | 7,862,997.02 | 7,396,157.34 | 8,019,165.78 | 7,533,710.39 |
| 一年内到期的非流动负债 | 20,308,131.83 | 17,795,506.95 | 17,799,487.9 | 17,816,184.11 |
| 其他流动负债 | 2,077,225.79 | 1,596,447.67 | 1,564,806.94 | 1,850,653.34 |
| 流动负债合计 | 430,580,658.95 | 380,408,565.34 | 365,803,331.93 | 329,891,054.95 |
| 非流动负债: | | | | |
| 长期借款 | 110,587,500 | 118,071,000 | 119,304,500 | 126,788,000 |
| 租赁负债 | 10,516,197.9 | 654,705.34 | 718,264.23 | 781,160.4 |
| 预计负债 | 21,375,121.5 | 22,502,534.84 | 25,675,274 | 26,785,386.29 |
| 递延收益 | 59,070,735.82 | 60,417,675.7 | 60,164,615.58 | 60,711,555.46 |
| 递延所得税负债 | 3,570,589.61 | 205,932.27 | 221,823.21 | 236,068.69 |
| 非流动负债合计 | 205,120,144.83 | 201,851,848.15 | 206,084,477.02 | 215,302,170.84 |
| 负债合计 | 635,700,803.78 | 582,260,413.49 | 571,887,808.95 | 545,193,225.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 649,036,700 | 649,036,700 | 649,036,700 | 649,036,700 |
| 资本公积 | 1,449,998,866.09 | 1,448,344,603.57 | 1,448,366,184.51 | 1,448,399,300.14 |
| 减:库存股 | 99,943,885.46 | 99,943,885.46 | 58,424,632.46 | - |
| 其他综合收益 | 413,942.35 | 1,193,983.62 | -47,282.65 | -930,684.14 |
| 盈余公积 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 |
| 未分配利润 | -527,399,832.49 | -470,597,121.72 | -425,504,302.46 | -366,027,001.02 |
| 归属于母公司股东权益合计 | 1,481,419,704.38 | 1,537,348,193.9 | 1,622,740,580.83 | 1,739,792,228.87 |
| 少数股东权益 | -148,796.59 | -155,762.72 | -277,670.58 | -244,713.64 |
| 股东权益合计 | 1,481,270,907.79 | 1,537,192,431.18 | 1,622,462,910.25 | 1,739,547,515.23 |
| 负债和股东权益合计 | 2,116,971,711.57 | 2,119,452,844.67 | 2,194,350,719.2 | 2,284,740,741.02 |
| 公告日期 | 2025-10-28 | 2025-08-19 | 2025-04-24 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |